Global industry-leading manufacturer of high-performance, innovative solutions and components across a wide range of industries.
Serving Biopharm and Cell Therapy
Industry-leading provider of material science-based solutions in the biopharmaceutical and cell therapy markets for single-use fluid management.
Medical Components and Custom Solutions
We provide custom components and engineered systems for the medical device industry, including critical parts where precision enables superior performance.
Electronics and Semiconductor Industry Solutions
Design and manufacture a complete line of ultra-high purity, fluoropolymer-based fluid handling components and solutions for the electronics and semiconductor markets.
Industrial & Consumer Solutions (ICS)
Superior engineering and customer support to achieve safety, performance, and regulatory compliance across a broad range of capabilities. Offerings include Tygon® Tubing and Accessories, Hoses and Fittings, Heat Shrink Tubing, and High-Performance Seals.
Sensors Flow Measurement Solutions
Playing an essential role in preventing cross-contamination, validating essential processes, and driving cost savings, we specialize in the development and production of high-quality single-use flow sensors and corresponding equipment.
Login
Don't have an account yet?
Click the button below to create a new account. Please fill in all fields and accept the Terms and Conditions. Personal email addresses will be denied. Your request will be reviewed within 2 business days, and you will receive a response via email.
This new production facility will enable us to expand our production capabilities for the supply of essential materials to the life sciences sector. Ireland is a global centre for the life sciences sector, and our company is a vital part of the supply chain for this key industry.
Sung Yu,
CEO of Saint-Gobain Life Sciences.
#general-text-193961
The products that are made have helped with the manufacture of drugs such as Covid-19 and HIV Therapies, Cancer, and Diabetes Drugs, Orphan Drugs for Rare Diseases, Vaccines as well as groundbreaking Cell and Gene therapies.
They established their presence in Ireland through acquisition in 2018 and have experienced rapid growth in both turnover and its number of employees, growing from just 19 employees in 2018.
